Priced at Rs 91,688 for a 350 mg vial, the prescription-only intravenous therapy is to be administered once a month for up to ...

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. BOSTON — A medicine increasingly used to ...

Patients — and their doctors — have been desperate for a more effective pancreatic cancer treatment for decades. Now one ...

A new class of drugs is saving the lives of children who once had no hope. These high-tech medicines can replace defective genes. But there's a catch. Many cost millions of dollars for a single dose.

A UAB clinical trial published in JAMA Network Open finds that psilocybin, combined with therapy, shows promise as a safe and ...

On March 20, the FDA approved Opdivo for adult and pediatric patients (aged 12 years and older) with previously untreated stage III or IV classical Hodgkin lymphoma when used in combination with ...

The U.S. Food and Drug Administration is reviewing a new Parkinson’s disease drug called tavapadon that could give people with the disease more control over their movements. If approved, it would be ...

Researchers at the University of California San Diego School of Medicine and international collaborators have led a worldwide, advanced study demonstrating the potential of tirzepatide, known to ...

Prevention of osteoporosis should be considered before a bone break occurs, and many patients at risk for the chronic bone condition may benefit from pharmacologic options. "Most current guidelines ...

SHELTON, CT / ACCESS Newswire / May 4, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the ...

A light at the end of the dark tunnel of depression? A report published by the Centers for Disease Control and Prevention last year revealed that nearly one in five adults in the US have been ...